Inhibitory effects of blockage of intermediate conductance Ca²⁺-activated K⁺ channels on proliferation of hepatocellular carcinoma cells

Abstract

The roles of intermediate conductance Ca²⁺-activated K⁺ channel (IKCa1) in the pathogenesis of hepatocellular carcinoma (HCC) were investigated. Immunohistochemistry and Western blotting were used to detect the expression of IKCa1 protein in 50 HCC and 20 para-carcinoma tissue samples. Real-time PCR was used to detect the transcription level of IKCa1 mRNA in 13 HCC and 11 para-carcinoma tissue samples. The MTT assay was used to measure the function of IKCa1 in human HCC cell line HepG2 in vitro. TRAM-34, a specific blocker of IKCa1, was used to intervene with the function of IKCa1. As compared with para-carcinoma tissue, an over-expression of IKCa1 protein was detected in HCC tissue samples (P<0.05). The mRNA expression level of IKCa1 in HCC tissues was 2.17 times higher than that in para-carcinoma tissues. The proliferation of HepG2 cells was suppressed by TRAM-34 (0.5, 1.0, 2.0 and 4.0 μmol/L) in vitro (P<0.05). Our results suggested that IKCa1 may play a role in the proliferation of human HCC, and IKCa1 blockers may represent a potential therapeutic strategy for HCC.

Keywords

intermediate conductance Ca²⁺-activated K⁺ channel / hepatocellular carcinoma / TRAM-34 / proliferation

References

[1] PariharA.S., CoghlanM.J., GopalakrishnanM., et al.. Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol, 2003, 471(3): 157-164

[2] JagerH., DrekerT., BuckA., et al.. Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol, 2004, 65(3): 630-638

[3] WangZ.H., ShenB., YaoH.L., et al.. Blockage of intermediate-conductance-Ca(2+)-activated K(+) channels inhibits progression of human endometrial cancer. Oncogene, 2007, 26(35): 5107-5114

[4] Ouadid-AhidouchH., RoudbarakiM., DelcourtP., et al.. Functional and molecular identification of intermediate-conductance Ca(2+)-activated K(+) channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol, 2004, 287(1): C125-134

[5] Lallet-DaherH., RoudbarakiM., BavencoffeA., et al.. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene, 2009, 28(15): 1792-1806

[6] WulffH., Kolski-AndreacoA., SankaranarayananA., et al.. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem, 2007, 14(13): 1437-1457

[7] BarfodE.T., MooreA.L., RoeM.W., et al.. Ca2+-activated IK1 channels associate with lipid rafts upon cell swelling and mediate volume recovery. J Biol Chem, 2007, 282(12): 8984-8993

[8] WulffH., MillerM.J., HanselW., et al.. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci USA, 2000, 97(14): 8151-8156

[9] ToyamaK., WulffH., ChandyK.G., et al.. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest, 2008, 118(9): 3025-3037

[10] WangZ.. Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch, 2004, 48(3): 274-286

[11] ValverdeP., KawaiT., TaubmanM.A.. Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease. J Dent Res, 2005, 84(6): 488-499

[12] El BoustanyC., BidauxG., EnfissiA., et al.. Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology, 2008, 47(6): 2068-2077

[13] PenaT.L., ChenS.H., KoniecznyS.F., et al.. Ras/MEK/ERK up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis. J Biol Chem, 2000, 275(18): 13677-13682

[14] GrgicI., EichlerI., HeinauP., et al.. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo. Arterioscler Thromb Vasc Biol, 2005, 25(4): 704-709

[15] MinguezB., TovarV., ChiangD., et al.. Pathogenesis of hepatocellular carcinoma and molecular therapies. Curr Opin Gastroenterol, 2009, 25(3): 186-194